Skip to main content

Advertisement

SpringerLink
Log in

eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril

  • Pharmacogenetics
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The antihypertensive effect of angiotensin-converting enzyme inhibitors (ACEi) is attributed partially to increased nitric oxide bioavailability. It is possible that functional polymorphisms in endothelial nitric oxide synthase (eNOS) and bradykinin receptor B2 (BDKRB2) genes may affect the antihypertensive response to enalapril.

Methods

We evaluated 106 hypertensive patients treated only with enalapril for 60 days. The difference between the mean arterial pressure (MAP) before and after the antihypertensive treatment was defined as ΔMAP. If ΔMAP were below or above the median value, the patients were classified as poor responders (PR) or good responders (GR), respectively. eNOS genotypes for the T-786C, G894T and 4b/4a polymorphisms were determined and haplotype frequencies were estimated by PHASE and Haplo.stats programs. The C-58T and BE1 +9/-9 polymorphisms of BDKRB2 genes and their haplotypes were determined by DNA sequencing. Robust multifactor dimensionality reduction analysis was used to characterize gene–gene interactions.

Results

The TC/CC genotypes and the C allele for the eNOS T-786C polymorphism were more frequent in GR than in PR. Furthermore, the TT genotype for the BDKRB2 C-58T polymorphism was more frequent in PR than GR. No other significant differences in genotypes or haplotypes were found. However, we found significant gene–gene interactions: the CC genotype for the BDKRB2 C-58T polymorphism was associated with response to enalapril depending on eNOS T-786C genotypes.

Conclusions

These findings suggest that eNOS T-786C and BDKRB2 C-58T polymorphisms may synergically affect the antihypertensive response to enalapril.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lawes CM, Vander Hoorn S, Rodgers A (2008) Global burden of blood-pressure-related disease, 2001. Lancet 371(9623):1513–1518

    Article  PubMed  Google Scholar 

  2. Linz W, Wohlfart P, Scholkens BA, Malinski T, Wiemer G (1999) Interactions among ACE, kinins and NO. Cardiovasc Res 43(3):549–561

    Article  PubMed  CAS  Google Scholar 

  3. Mason RP, Cockcroft JR (2006) Targeting nitric oxide with drug therapy. J Clin Hypertens (Greenwich) 8(12 Suppl 4):40–52

    Article  CAS  Google Scholar 

  4. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A (2005) The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 99(1):6–38

    Article  PubMed  CAS  Google Scholar 

  5. Bachetti T, Comini L, Pasini E, Cargnoni A, Curello S, Ferrari R (2001) Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats. J Mol Cell Cardiol 33(3):395–403

    Article  PubMed  CAS  Google Scholar 

  6. Comini L, Bachetti T, Cargnoni A, Bastianon D, Gitti GL, Ceconi C, Ferrari R (2007) Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent. Pharmacol Res 56(1):42–48

    Article  PubMed  CAS  Google Scholar 

  7. De Gennaro CV, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G (2005) Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol 516(3):253–259

    Article  Google Scholar 

  8. Miguel-Carrasco JL, Monserrat MT, Mate A, Vazquez CM (2010) Comparative effects of captopril and l-carnitine on blood pressure and antioxidant enzyme gene expression in the heart of spontaneously hypertensive rats. Eur J Pharmacol 632(1–3):65–72

    Article  PubMed  CAS  Google Scholar 

  9. Hornig B, Kohler C, Drexler H (1997) Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 95(5):1115–1118

    Article  PubMed  CAS  Google Scholar 

  10. Joshi MS, Mineo C, Shaul PW, Bauer JA (2007) Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J 21(11):2655–2663

    Article  PubMed  CAS  Google Scholar 

  11. Miyamoto Y, Saito Y, Nakayama M, Shimasaki Y, Yoshimura T, Yoshimura M, Harada M, Kajiyama N, Kishimoto I, Kuwahara K, Hino J, Ogawa E, Hamanaka I, Kamitani S, Takahashi N, Kawakami R, Kangawa K, Yasue H, Nakao K (2000) Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T–> C mutation associated with coronary spastic angina. Hum Mol Genet 9(18):2629–2637

    Article  PubMed  CAS  Google Scholar 

  12. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K (1999) T-786–> C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99(22):2864–2870

    Article  PubMed  CAS  Google Scholar 

  13. Zhang MX, Zhang C, Shen YH, Wang J, Li XN, Chen L, Zhang Y, Coselli JS, Wang XL (2008) Effect of 27nt small RNA on endothelial nitric-oxide synthase expression. Mol Biol Cell 19(9):3997–4005

    Article  PubMed  CAS  Google Scholar 

  14. Zhang MX, Zhang C, Shen YH, Wang J, Li XN, Zhang Y, Coselli J, Wang XL (2008) Biogenesis of short intronic repeat 27-nucleotide small RNA from endothelial nitric-oxide synthase gene. J Biol Chem 283(21):14685–14693

    Article  PubMed  CAS  Google Scholar 

  15. Metzger IF, Ishizawa MH, Rios-Santos F, Carvalho WA, Tanus-Santos JE (2011) Endothelial nitric oxide synthase gene haplotypes affect nitrite levels in black subjects. Pharmacogenomics J 11(6):393–399

    Article  PubMed  CAS  Google Scholar 

  16. Metzger IF, Sertorio JT, Tanus-Santos JE (2007) Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med 43(6):987–992

    Article  PubMed  CAS  Google Scholar 

  17. Metzger IF, Souza-Costa DC, Marroni AS, Nagassaki S, Desta Z, Flockhart DA, Tanus-Santos JE (2005) Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics 15(8):565–570

    Article  PubMed  CAS  Google Scholar 

  18. Hyndman ME, Parsons HG, Verma S, Bridge PJ, Edworthy S, Jones C, Lonn E, Charbonneau F, Anderson TJ (2002) The T-786–> C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension 39(4):919–922

    Article  PubMed  CAS  Google Scholar 

  19. Nejatizadeh A, Kumar R, Stobdan T, Goyal AK, Sikdar S, Gupta M, Javed S, Pasha MA (2008) Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension. Free Radic Biol Med 44(11):1912–1918

    Article  PubMed  CAS  Google Scholar 

  20. Sandrim VC, Palei AC, Cavalli RC, Araujo FM, Ramos ES, Duarte G, Tanus-Santos JE (2008) eNOS haplotypes associated with gestational hypertension or preeclampsia. Pharmacogenomics 9(10):1467–1473

    Article  PubMed  CAS  Google Scholar 

  21. Vasconcellos V, Lacchini R, Jacob-Ferreira AL, Sales ML, Ferreira-Sae MC, Schreiber R, Nadruz W, Tanus-Santos JE (2010) Endothelial nitric oxide synthase haplotypes associated with hypertension do not predispose to cardiac hypertrophy. DNA Cell Biol 29(4):171–176

    Article  PubMed  CAS  Google Scholar 

  22. Lee YC, Wu WJ, Liu CC, Wang CJ, Li WM, Huang CH, Yeh HC, Ke HL, Huang SP (2009) The associations among eNOS G894T gene polymorphism, erectile dysfunction, and benign prostate hyperplasia-related lower urinary tract symptoms. J Sex Med 6(11):3158–3165

    Article  PubMed  CAS  Google Scholar 

  23. Napoli C, Ignarro LJ (2007) Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis. J Clin Pathol 60(4):341–344

    Article  PubMed  CAS  Google Scholar 

  24. Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, Tanus-Santos JE (2006) Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 186(2):428–432

    Article  PubMed  CAS  Google Scholar 

  25. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE (2006) Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 189(1):241–246

    Article  PubMed  CAS  Google Scholar 

  26. Braun A, Kammerer S, Maier E, Bohme E, Roscher AA (1996) Polymorphisms in the gene for the human B2-bradykinin receptor. New tools in assessing a genetic risk for bradykinin-associated diseases. Immunopharmacology 33(1–3):32–35

    Article  PubMed  CAS  Google Scholar 

  27. Braun A, Maier E, Kammerer S, Muller B, Roscher AA (1996) A novel sequence polymorphism in the promoter region of the human B2-bradykinin receptor gene. Hum Genet 97(5):688–689

    Article  PubMed  CAS  Google Scholar 

  28. Dhamrait SS, Payne JR, Li P, Jones A, Toor IS, Cooper JA, Hawe E, Palmen JM, Wootton PT, Miller GJ, Humphries SE, Montgomery HE (2003) Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension. Eur Heart J 24(18):1672–1680

    Article  PubMed  CAS  Google Scholar 

  29. Hallberg P, Lind L, Michaelsson K, Karlsson J, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nystrom F, Melhus H (2003) B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. J Hypertens 21(3):621–624

    Article  PubMed  CAS  Google Scholar 

  30. Niu W, Qi Y, Gao P, Zhu D (2010) A meta-analysis of the bradykinin B2 receptor gene –58C/T polymorphism with hypertension. Clin Chim Acta 411(5–6):324–328

    Article  PubMed  CAS  Google Scholar 

  31. Lacchini R, Silva PS, Tanus-Santos JE (2010) A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins. Basic Clin Pharmacol Toxicol 106(5):357–361

    PubMed  CAS  Google Scholar 

  32. Muniz JJ, Lacchini R, Rinaldi TO, Nobre YT, Cologna AJ, Martins AC, Tanus-Santos JE (2011) Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction. Pharmacogenomics J

  33. Nagassaki S, Sertorio JT, Metzger IF, Bem AF, Rocha JB, Tanus-Santos JE (2006) eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic Biol Med 41(7):1044–1049

    Article  PubMed  CAS  Google Scholar 

  34. Peskircioglu L, Atac FB, Erdem SR, Deveci S, Verdi H, Ozkardes H (2007) The association between intron 4 VNTR, E298A and IVF 23 + 10G/T polymorphisms of ecNOS gene and sildenafil responsiveness in patients with erectile dysfunction. Int J Impot Res 19(2):149–153

    Article  PubMed  CAS  Google Scholar 

  35. Van Guilder GP, Pretorius M, Luther JM, Byrd JB, Hill K, Gainer JV, Brown NJ (2008) Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition. Hypertension 51(2):454–459

    Article  PubMed  Google Scholar 

  36. Tanus-Santos JE, Desai M, Flockhart DA (2001) Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11(8):719–725

    Article  PubMed  CAS  Google Scholar 

  37. Pretorius MM, Gainer JV, Van Guilder GP, Coelho EB, Luther JM, Fong P, Rosenbaum DD, Malave HA, Yu C, Ritchie MD, Vaughan DE, Brown NJ (2008) The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance. Clin Pharmacol Ther 83(1):122–129

    Article  PubMed  CAS  Google Scholar 

  38. Menashe I, Rosenberg PS, Chen BE (2008) PGA: power calculator for case-control genetic association analyses. BMC Genet 9:36

    Article  PubMed  Google Scholar 

  39. Pander J, Wessels JA, Mathijssen RH, Gelderblom H, Guchelaar HJ (2011) Pharmacogenetics of tomorrow: the 1 + 1 = 3 principle. Pharmacogenomics 11(7):1011–1017

    Article  Google Scholar 

  40. Ritchie MD, Motsinger AA (2005) Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies. Pharmacogenomics 6(8):823–834

    Article  PubMed  CAS  Google Scholar 

  41. Gui J, Andrew AS, Andrews P, Nelson HM, Kelsey KT, Karagas MR, Moore JH (2011) A robust multifactor dimensionality reduction method for detecting gene-gene interactions with application to the genetic analysis of bladder cancer susceptibility. Ann Hum Genet 75(1):20–28

    Article  PubMed  Google Scholar 

  42. Abe K, Nakayama M, Yoshimura M, Nakamura S, Ito T, Yamamuro M, Sakamoto T, Miyamoto Y, Yoshimasa Y, Saito Y, Nakao K, Yasue H, Ogawa H (2005) Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the -786T > C polymorphism. Pharmacogenet Genomics 15(5):329–336

    Article  PubMed  CAS  Google Scholar 

  43. Mason RP, Jacob RF, Kubant R, Jacoby A, Louka F, Corbalan JJ, Malinski T (2012) Effects of angiotensin receptor blockers on endothelial nitric oxide release - The role of eNOS variants. Br J Clin Pharmacol

  44. Souza-Costa DC, Sandrim VC, Lopes LF, Gerlach RF, Rego EM, Tanus-Santos JE (2007) Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene. Atherosclerosis 193(2):438–444

    Article  PubMed  CAS  Google Scholar 

  45. Nagassaki S, Herculano RD, Graeff CF, Tanus-Santos JE (2009) eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. Eur J Clin Pharmacol 65(4):385–392

    Article  PubMed  CAS  Google Scholar 

  46. Tanus-Santos JE, Desai M, Deak LR, Pezzullo JC, Abernethy DR, Flockhart DA, Freedman JE (2002) Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics 12(5):407–413

    Article  PubMed  CAS  Google Scholar 

  47. Zago AS, Kokubun E, Fenty-Stewart N, Park JY, Attipoe S, Hagberg J, Brown M (2010) Effect of physical activity and t-786C polymorphism in blood pressure and blood flow in the elderly. Arq Bras Cardiol 95(4):510–516

    Article  PubMed  CAS  Google Scholar 

  48. Sandrim VC, Palei AC, Luizon MR, Izidoro-Toledo TC, Cavalli RC, Tanus-Santos JE (2010) eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension. Pharmacogenomics J 10(1):40–45

    Article  PubMed  CAS  Google Scholar 

  49. Erdos EG, Tan F, Skidgel RA (2010) Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension 55(2):214–220

    Article  PubMed  Google Scholar 

  50. Mukae S, Aoki S, Itoh S, Iwata T, Ueda H, Katagiri T (2000) Bradykinin B(2) receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough. Hypertension 36(1):127–131

    Article  PubMed  CAS  Google Scholar 

  51. Mukae S, Itoh S, Aoki S, Iwata T, Nishio K, Sato R, Katagiri T (2002) Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough. J Hum Hypertens 16(12):857–863

    Article  PubMed  CAS  Google Scholar 

  52. Lee YJ, Tsai JC (2001) Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism 50(11):1346–1350

    Article  PubMed  CAS  Google Scholar 

  53. Woo SW, Bang S, Chung MW, Jin SK, Kim YS, Lee SH (2009) Lack of association between ACE and bradykinin B2 receptor gene polymorphisms and ACE inhibitor-induced coughing in hypertensive Koreans. J Clin Pharm Ther 34(5):561–567

    Article  PubMed  CAS  Google Scholar 

  54. Grilo A, Saez-Rosas MP, Santos-Morano J, Sanchez E, Moreno-Rey C, Real LM, Ramirez-Lorca R, Saez ME (2011) Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough. Pharmacogenet Genomics 21(1):10–17

    Article  PubMed  CAS  Google Scholar 

  55. Sandrim VC, Yugar-Toledo JC, Desta Z, Flockhart DA, Moreno H Jr, Tanus-Santos JE (2006) Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy. J Hypertens 24(12):2393–2397

    Article  PubMed  CAS  Google Scholar 

  56. Silva PS, Fontana V, Palei AC, Sertorio JT, Biagi C, Tanus-Santos JE (2011) Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. Eur J Clin Pharmacol 67(4):365–370

    Article  PubMed  CAS  Google Scholar 

  57. Marroni AS, Metzger IF, Souza-Costa DC, Nagassaki S, Sandrim VC, Correa RX, Rios-Santos F, Tanus-Santos JE (2005) Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12(3):177–182

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP).

Author information

Authors and Affiliations

  1. Department of Pharmacology, State University of Campinas, Campinas, SP, Brazil

    P. S. Silva

  2. Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Av. Bandeirantes, 3900, 14049-900, Ribeirao Preto, SP, Brazil

    V. Fontana, M. R. Luizon, R. Lacchini & J. E. Tanus-Santos

  3. Department of Genetics, Faculty of Medicine of Ribeirao Preto, Ribeirao Preto, SP, Brazil

    W. A. Silva Jr.

  4. Santa Casa of Araçatuba, Araçatuba, SP, Brazil

    C. Biagi

Authors
  1. P. S. Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Fontana
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. R. Luizon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Lacchini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. A. Silva Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Biagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. E. Tanus-Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. E. Tanus-Santos.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 734 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silva, P.S., Fontana, V., Luizon, M.R. et al. eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril. Eur J Clin Pharmacol 69, 167–177 (2013). https://doi.org/10.1007/s00228-012-1326-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-012-1326-2

Keywords

Search

Navigation